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CC BY-NC-ND license (http://creativeBackground: Screening for infectious diseases in newborns using immunoglobulin (Ig)A-, IgM-,
and IgE-specific antibodies is expensive and impractical. To determine if total levels of these
Igs can be used for screening purposes, thus simplifying the process, their basic levels in the 1st
month of extrauterine life need to be determined. Additionally, the ability to simplify
screening by using saliva also needs to be determined. The aim of this study was to determine
IgA, IgM, and IgE concentrations in plasma and saliva in newborns, correlation between the
samples, and relationship between Ig levels and newborn age.
Methods: We enrolled 53 apparently healthy newborns, paired samples of plasma and saliva
were collected, and total IgA, IgM, and IgE concentrations determined by capture enzyme-
linked immunosorbent assay. The correlation between plasma and saliva values was calculated
by Spearman’s rank correlation coefficient and the IgA, IgM, and IgE distributions were
analyzed by the Shapiro-Wilk test. We also determined the level of each Ig concentration ac-
cording to age.
Results: IgA and IgM levels in plasma and IgA levels in saliva increased significantly during 1st
month of life, especially in the 2nd week and 3rd week, with a good correlation of IgA between
plasma and saliva. IgE levels in both plasma and saliva and IgM levels in saliva were very low or
absent.de Errores Innatos del Metabolismo y Tamiz, Instituto Nacional de Pediatrı´a, Avenida Insurgentes Sur
C.P. 04530, Me´xico, D.F., Mexico.
hoo.com (M. Vela-Amieva).
015.06.005
Pediatric Association. Published by Elsevier Taiwan LLC. This is an open access article under the
commons.org/licenses/by-nc-nd/4.0/).
214 S. Pineda-Martı´nez et alConclusion: These results suggest that Igs in saliva could be good biomarkers for newborn
screening programs during the 1st week of life. This study established reference values for
Igs according to age in the neonatal period.
Copyright ª 2015, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Immunoglobulins (Igs) are humoral immunity molecules
produced in response to internal and external antigens.1
These proteins are synthesized in utero from the 1st week
of gestation in response to maternal or other substances
that cross the placenta, or as result of an active infection of
the fetus.2 Different Ig types are present in neonatal blood,
with IgG being a mixture of antibodies synthesized by the
fetus and those of the mother transferred by the chorionic
villi FcRn receptor.3 Conversely, maternal IgA, IgM, and IgE
antibodies do not cross the placenta, therefore, these
concentrations reflect the fetal immune response.4
Abnormal IgM, IgA, or IgE levels have been found as a
result of fetal or newborn response to congenital in-
fections, sepsis, allergies, stress, or exposure to environ-
mental toxins (i.e., lead). Therefore, the detection of
abnormal levels of these Igs could be useful for identifica-
tion of health risks in the neonate.5e9 In fact, postnatal
screening programs for congenital infectious diseases, such
as toxoplasmosis, have been implemented based on the
search for specific antibodies associated with these Igs as
primary biomarkers.9,10
Immunoglobulins are usually measured in venous or
capillary blood, however, alternative samples, including
saliva, have also been used for young children, given the
non-invasive nature and ease of collection.11 Specific an-
tibodies against Trypanosoma cruzi, Toxoplasma gondii,
and hepatitis B and C have been found in adult saliva,
however, studies in newborns or infants using this sample as
a biological matrix are scant.12e15 Although total IgM and
IgA levels have been measured in serum from the umbilical
cord and 1-month-old infants, there are few data con-
cerning their concentrations within the neonatal period.16
Moreover, IgM and IgE levels in newborn saliva are practi-
cally unknown.17e23 Therefore, the objective of this study
was to determine total IgA, IgM, and IgE concentrations in
the plasma and saliva of newborns, the correlation between
samples, and the relationships between these levels and
age.
2. Methods
2.1. Studied population and data collection
The study included a subset of newborns who participated
in the large multicenter project, “Prenatal and neonatal
screening for congenital infections in Mexico City”. The
study protocol was approved by the Research and Ethics
Reviewing Board of Instituto Nacional de Pediatrı´a,Me´xico, D.F., Mexico (registry number 002/2008). All pro-
cedures were explained to the parents or guardians, who
signed an informed consent form. Apparently healthy
children born at the Hospital General Dr. Manuel Gea
Gonza´lez in Mexico City, Mexico were enrolled in this
study. Only those cases with effective paired blood and
saliva samples were included for the analysis. The exclu-
sion criteria were the presence of maternal chronic dis-
ease, as well as a low Apgar score at birth (< 6 at 1 minute
or 5 minutes), a congenital abnormality, suspected infec-
tion, or transfusion with blood derivatives between birth
and the day of sample collection.
Information on gestational age, health of mother and of
child, and type of newborn feeding was obtained by an
interview with the guardian and clinical data from the
hospital.
2.2. Sample collection
All samples were collected from newborns following a 2
hour fast. Whole unstimulated saliva (100 mL) was obtained
using sterile polypropylene transfer pipettes and placed in
tubes with 3104 g protease-inhibitor cocktail (Sigma
P2714; Sigma-Aldrich, St. Louis, MO, USA). Samples were
transported on ice to the laboratory where they were
centrifuged at 176 g for 5 minutes and the supernatants
stored at 80C until analysis.
Blood samples were obtained by venopuncture using
Becton Dickinson devices (Sigma-Aldrich). Blood was
initially sampled in a heparinized Vacutainer tube (BD
Bioscience, Franklin Lakes, NJ, USA), plasma separated by
centrifugation, and aliquots prepared, frozen, and stored
at 80C until use.
2.3. Immunoglobulin quantification
Total IgA, IgM, and IgE concentrations in saliva and plasma
were determined by capture enzyme-linked immunosor-
bent assay (ELISA). Briefly, 96-well plates (Maxisorb Nalge
Nunc International, Rochester, NY, USA) were coated with
100 mL of the capture antibodies (anti-IgA, 2 mg/mL; anti-
IgM, 0.125 mg/mL; and anti-IgE, 3 mg/mL) in 0.01M borate
buffer (pH 8.0) and incubated at 4C overnight. At each
reaction step, three 5-minute washes with 200 mL 0.01M
phosphate-buffered saline (PBS; pH 7.2) with 0.5% Tween
20 (PBS-T) and two 5-minute washes with PBS only were
undertaken. The nonspecific-binding free sites were
blocked with 1% albumin diluted in PBS-T (200 mL/well) by
incubation at 37C for 30 minutes.
Samples were processed by two-fold serial dilutions
starting at ratios of 1:160, 1:500, and 1:40 for IgA, IgM, and
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IgM and IgE in the case of saliva, and samples (100 mL/well)
were incubated for 2 hours at 37C. Then, 100 mL/well of
peroxidase-conjugated anti-IgA (1:4000), anti-IgM (1:2000),
or anti-IgE (1:1000) were added and incubated under the
same conditions. The presence of labeled antibodies was
revealed using 100 mL/well of chromogenic substrate solu-
tion prepared with 5 mL sodium citrate, 5 mL citric acid,
4 mL hydrogen peroxide, and 10 mg O-phenylenediamine
dihidrochloride (Sigma-Aldrich). The reaction was stopped
by adding 50 mL/well 0.1 N sulfuric acid and the absorbance
measured in a Turner Microplate Biosystems Modulus ELISA
plate reader (Turner Biosystems Inc., Sunnyvale, CA, USA)
at 490 nm. IgM, IgA, or IgE standard curves were obtained
for each plate to determine the concentration of each
sample by absorbance interpolation and multiplication by
the dilution factor.2.4. Statistical analysis
Correlation between plasma- and saliva-sample concen-
trations was determined by Spearman’s rank correlation
coefficient. Descriptive statistics (mean values) and 95%
confidence intervals were calculated. Each Ig-
concentration distribution was analyzed by Shapiro-Wilk
test using the statistical program Stata version 11.1 Sta-
tistics (StataCorp., College Station, TX, USA). Data were
graphed in order to visualize the dispersion of each Ig
concentration in relation to age. Comparison of Ig con-
centrations among samples from children fed exclusively
with breast milk or a combination of formula and breast
milk was made by ManneWhitney U test.3. Results3.1. Population data
Paired plasma and saliva samples from 53 apparently
healthy newborns were obtained, with 31 males (58.5%) and
22 females (41.5%). Mean gestational age at birth was 38.6
weeks [standard deviation (SD), 1.42; range, 34.2e41.6].
Mean birth weight was 2976.3 g (SD, 496.4; range,
857.0e3918 g), while mean height was 48.8 cm (SD, 2.5;
range, 38.0e53.0 cm). Age at sample collection was 15.4
days (SD, 6.75; range, 1e29 days). Forty-two childrenTable 1 Mean IgA, IgM, and IgE concentrations in newborn plas
Sample type Mean  SD 95% C
IgA Plasma 54.1  63.8 36.5e
Saliva 24.5  33.2 15.3e
IgM Plasma 641.3  616.0 471.5e
Saliva 3.6  12.4 0.2e
IgE* Plasma 0.5  1.2 0.1e
Saliva 0.5  0.7 0.2e
Data are presented as concentrations (mg/mL).
* IgE was determined only in 43 newborns because the remaining sam
CI Z confidence interval; Ig Z immunoglobulin; SD Z standard devia(79.2%) were full term, five children (9.5%) were pre-term,
and six children (11.3%) were post-term.
Almost half (48.9%) of the newborns were exclusively
breastfed, while the rest (51.1%) received a combination of
breast milk and formula. Five of the newborns received
formula exclusively.
3.2. Immunoglobulin levels
The Ig concentrations in plasma and saliva are shown in
Table 1. None of the Ig levels presented normal distribu-
tions in plasma or saliva. IgM values in saliva were null, and
IgE in both plasma and saliva samples were almost
undetectable.
A significant positive relationship between age and total
IgA and IgM levels in plasma and IgA levels in saliva was
observed during the 1st month of life, with very low levels
observed in the 1st week (Figures 1 and 2). Conversely, IgE
concentrations were unrelated to age in the neonatal
period (Figure 3). Statistically significant correlations be-
tween plasma and saliva samples were observed only for
IgA (rs Z 0.6; p < 0.001).
IgM values in saliva were slightly higher in those infants
fed with a combination of breast milk and formula (mean,
28.1 mg/mL) as compared to those exclusively undergoing
breast feeding (mean, 19.7 mg/mL, p Z 0.026).4. Discussion
Following birth, the newborn is exposed to a very different
environment charged with antigens, including normal flora
microorganisms, vaccines, and breast or formula milk. The
exposure to these immunogenic substances may cause an
immune response and the creation of antibodies, which is
likely to be reflected by changes in total Ig values. Few
studies have examined total concentration of various Ig
classes in umbilical cord or peripheral blood from infants.
Jolliff et al16 followed a cohort monthly up to the 1st year
of life and annually for 12 years, however, variations
observed within the 1st month were not studied. This
period represents an important adaptation phase of the
individual to the environment involving multiple physio-
logical changes, therefore, variations in Ig levels are to be
expected.21e25 The main contribution of this study was our
demonstrated significant correlation between age and IgA
levels in both plasma and saliva, as well as IgM levels inma and saliva (n Z 53).
I Minimum Maximum Median
71.7 0.3 317.4 36.1
33.6 0.0 132.0 6.7
811.1 3.2 2929.9 419.5
7.1 0.0 80.5 0.0
0.8 0.0 5.0 0.0
0.7 0.0 2.7 0.1
ples were insufficient for analysis.
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Figure 1 IgA concentration in plasma and saliva of neonates at different ages. Each dot represents one newborn (n Z 53).
IgA Z immunoglobulin A.
216 S. Pineda-Martı´nez et alplasma, within the 1st month of life, although this ten-
dency was not observed for either IgM in saliva or for IgE in
plasma or saliva. It is important to note that IgM and IgE
values in saliva samples from the 1st week of life were
practically null, which could make them useful markers
indicating in utero exposure to allergens, infections, or
other toxins.4e9
The concentrations of IgA in plasma and saliva and of IgM
in plasma were much higher in neonates older than 2
weeks. These findings are important for establishing Ig
neonatal reference values for the design of newborn
screening programs based on these Igs as biomarkers. They0
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Figure 2 IgM concentration in plasma and saliva of neonates a
IgA Z immunoglobulin A.may also be useful for establishing proper sampling times,
which are likely between the 1st day and 7th day of life.
Since it is a secretory protein of mucosa, we confirmed
our expectations to observe IgA in saliva. Previous reports
involving Latin American populations from Chile and
Venezuela showed IgA concentrations of 32.9 mg/mL and
30.0 mg/mL, respectively, with variations similar to those
reported here.19,20
The correlation of IgA values between plasma and saliva
observed here support the use of the latter as a good
alternative for screening studies, given that the sample
collection is simple, low-cost, non-invasive, and acceptablee (d)
0
30
60
90
0 7 14 21 28
Saliva
t different ages. Each dot represents one newborn (n Z 53).
01
2
3
4
5
6
0 7 14 21 28
Ig
E
(μ
g\
m
L)
Age (d)
0
1
2
3
4
5
6
0 7 14 21 28
SalivaPlasma
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Immunoglobulins during neonatal period 217to parents. Unlike previous studies, we found no effect of
the feeding type on IgA levels. Additionally, these studies
examined antigen-specific antibodies, while we measured
the total IgA concentration.24,25 Interestingly, total IgM
appeared correlated to formula feeding. Although this
correlation was not statistically significant, this finding
could be biologically relevant and should be taken into
account to determine reference levels.
There is a need to establish normal ranges for IgA, IgM,
and IgE levels in blood and saliva samples in early infancy,
given their potential use as biomarkers for the diagnosis of
diverse diseases. In this study conducted in apparently
healthy newborns, we found cases with very high plasmatic
levels of IgA (> 200 mg/mL) or IgM (> 1000 mg/mL). These
children were not harboring an infectious disease associ-
ated with TORCH (Toxoplasma, rubella, cytomegalovirus,
herpes simplex and other agents) syndrome, such as syph-
ilis, HBV, or HBC, as determined by laboratory and clinically
specific diagnosis. High levels of Igs can also be related to
other factors, such as maternal immunization just prior to
or during pregnancy, substance abuse, allergies, or hyper-
immunoglobulin syndromes.5e9,26 Unfortunately, we did not
take these factors into account, therefore, they must be
included in future studies on this topic. Furthermore, the
small sample size necessitates study of larger groups to
definitively establish relationships between high levels of
Igs to specific biological or pathological features.
We observed significant increases in levels of IgA and IgM
in serum and saliva during the 1st month of life, especially
in the 2nd week and 3rd week. Our study contributes to
establishing reference values according to age in the
neonatal period. IgA determination in saliva may be a good
biomarker for possible newborn screening programs, with
the ideal sampling age being from Day 1 to Day 7 of life.
Conversely, both samples exhibited low IgE levels, indi-
cating the possibility that high levels of this Ig should be
examined carefully by clinicians, although further studies
regarding this finding are needed.Conflicts of interest
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